Proteomic contributions to our understanding of vaccine and immune responses

No abstract is available for this paper.

• Publication year

  2015

• Venue

  PROTEOMICS - Clinical Applications

• Publication date

  2015-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/prca.201500054PMID 26172619PMCID PMC4713355
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of cytokine responses during influenza virus pathogenesis and potential therapeutic options.

  2015cited by this paper
• Discovering protective CD8 T cell epitopes--no single immunologic property predicts it!

  2015cited by this paper
• Outer membrane proteins preferentially load MHC class II peptides: implications for a Chlamydia trachomatis T cell vaccine.

  2015cited by this paper
• Neoantigens in cancer immunotherapy

  2015cited by this paper
• RSV Vaccine-Enhanced Disease Is Orchestrated by the Combined Actions of Distinct CD4 T Cell Subsets

  2015cited by this paper
• A Cell-Based Systems Biology Assessment of Human Blood to Monitor Immune Responses after Influenza Vaccination

  2015cited by this paper
• The Viral Transcription Group Determines the HLA Class I Cellular Immune Response Against Human Respiratory Syncytial Virus*

  2015influential reference
• Characterization of protective extracellular membrane-derived vesicles produced by Streptococcus pneumoniae.

  2014influential reference
• Checkpoint Blockade Cancer Immunotherapy Targets Tumour-Specific Mutant Antigens

  2014cited by this paper
• Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-120 interface

  2014cited by this paper
• Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing

  2014cited by this paper
• Quantification by LC-MS(E) of outer membrane vesicle proteins of the Bexsero® vaccine.

  2014cited by this paper
• Systems vaccinology: Probing humanity’s diverse immune systems with vaccines

  2014cited by this paper
• Vaccines against tropical parasitic diseases: a persisting answer to a persisting problem

  2014cited by this paper
• Identification and characterization of the constituent human serum antibodies elicited by vaccination

  2014cited by this paper
• Identification of vaccine antigens using integrated proteomic analyses of surface immunogens from serogroup B Neisseria meningitidis.

  2014cited by this paper
• Innate immunity to influenza virus infection

  2014cited by this paper
• Hemagglutinin stalk domain from H5N1 strain as a potentially universal antigen.

  2014cited by this paper
• Epitope-based approaches to a universal influenza vaccine.

  2014influential reference
• Proteomics-Identified Bvg-Activated Autotransporters Protect against Bordetella pertussis in a Mouse Model

  2014cited by this paper
• Malaria proteomics: insights into the parasite-host interactions in the pathogenic space.

  2014cited by this paper
• The role of cell proteins in dengue virus infection.

  2014cited by this paper
• A universal flu vaccine.

  2014cited by this paper
• Isolation of Dengue Virus-Specific Memory B Cells with Live Virus Antigen from Human Subjects following Natural Infection Reveals the Presence of Diverse Novel Functional Groups of Antibody Clones

  2014cited by this paper
• The emergence of proteome-wide technologies: systematic analysis of proteins comes of age

  2014cited by this paper
• A review on recent developments in mass spectrometry instrumentation and quantitative tools advancing bacterial proteomics

  2013cited by this paper
• A Field Trial to Assess a Blood-Stage Malaria Vaccine

  2013cited by this paper
• Proteomic analysis of schistosomiasis japonica vaccine candidate antigens recognized by UV-attenuated cercariae-immunized porcine serum IgG2

  2013cited by this paper
• T-cell epitope vaccine design by immunoinformatics

  2013cited by this paper
• Discovering naturally processed antigenic determinants that confer protective T cell immunity.

  2013cited by this paper
• Quantitative proteomics reveals distinct differences in the protein content of outer membrane vesicle vaccines.

  2013influential reference
• Defective immunoregulation in RSV vaccine-augmented viral lung disease restored by selective chemoattraction of regulatory T cells

  2013cited by this paper
• Comparison of the membrane proteome of virulent Mycobacterium tuberculosis and the attenuated Mycobacterium bovis BCG vaccine strain by label-free quantitative proteomics.

  2013cited by this paper
• 'Omics investigations of HIV and SIV pathogenesis and innate immunity.

  2013cited by this paper
• Molecular signatures of antibody responses derived from a systems biological study of 5 human vaccines

  2013cited by this paper
• Characterization of Influenza Vaccine Immunogenicity Using Influenza Antigen Microarrays

  2013cited by this paper
• Accelerating Next-Generation Vaccine Development for Global Disease Prevention

  2013cited by this paper
• Prospects of combinatorial synthetic peptide vaccine-based immunotherapy against cancer.

  2013cited by this paper
• Apoptosis and other immune biomarkers predict influenza vaccine responsiveness

  2013cited by this paper
• Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.

  2013cited by this paper
• Proteomics as a novel HIV immune monitoring tool

  2013cited by this paper
• Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine

  2013cited by this paper
• 56 – Parasitic disease vaccines

  2013cited by this paper
• Emerging protein array technologies for proteomics

  2013cited by this paper
• Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.

  2013cited by this paper
• Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines

  2013cited by this paper
• Systems biological approaches to measure and understand vaccine immunity in humans.

  2013cited by this paper
• Universal flu vaccine?

  2013cited by this paper
• Construction and Evaluation of a Novel Recombinant T Cell Epitope-Based Vaccine against Coccidioidomycosis

  2012cited by this paper
• Label‐free mass spectrometry‐based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines

  2012cited by this paper
• Another turn of the screw in shaving Gram-positive bacteria: Optimization of proteomics surface protein identification in Streptococcus pneumoniae.

  2012cited by this paper
• Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC-MSE.

  2012cited by this paper
• Quantitative Mass Spectrometry-Based Proteomics: An Overview

  2012cited by this paper
• Quantitative proteomic analysis of HIV-1 infected CD4+ T cells reveals an early host response in important biological pathways: protein synthesis, cell proliferation, and T-cell activation.

  2012cited by this paper
• Dengue virus infection induces upregulation of hn RNP-H and PDIA3 for its multiplication in the host cell.

  2012cited by this paper
• Identification of plasma-responsive outer membrane proteins and their vaccine potential in Edwardsiella tarda using proteomic approach.

  2012cited by this paper
• Improved proteomic approach for the discovery of potential vaccine targets in Trypanosoma cruzi.

  2012cited by this paper
• Vaxjo: A Web-Based Vaccine Adjuvant Database and Its Application for Analysis of Vaccine Adjuvants and Their Uses in Vaccine Development

  2012cited by this paper
• Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions

  2012cited by this paper
• Systems biology in vaccine design

  2012cited by this paper
• Genome-wide correlation between mRNA and protein in a single cell.

  2011cited by this paper
• Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humans.

  2011cited by this paper
• Proteomic Footprinting of Drug-Treated Cancer Cells as a Measure of Cellular Vaccine Efficacy for the Prevention of Cancer Recurrence*

  2011cited by this paper
• Proteomic profile of culture filtrate from the Brazilian vaccine strain Mycobacterium bovis BCG Moreau compared to M. bovis BCG Pasteur

  2011cited by this paper
• Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

  2011cited by this paper
• Systems Biology of Seasonal Influenza Vaccination in Humans

  2011cited by this paper
• A field trial to assess a blood-stage malaria vaccine.

  2011cited by this paper
• Clinical applications of DNA vaccines: current progress.

  2011cited by this paper
• Proteomic and immunoproteomic characterization of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae

  2011cited by this paper
• Immune responses to influenza virus infection.

  2011influential reference
• Proteomics for development of vaccine.

  2011influential reference
• Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA−NP+M1

  2011cited by this paper
• Proteomic characterization and functional analysis of outer membrane vesicles of Francisella novicida suggests possible role in virulence and use as a vaccine.

  2011influential reference
• New developments in vaccine research--unveiling the secret of vaccine adjuvants.

  2011cited by this paper
• The ubiquitin-proteasome pathway is important for dengue virus infection in primary human endothelial cells.

  2010cited by this paper
• Advances in vaccination against Helicobacter pylori

  2010cited by this paper
• New insights for development of a safe and protective RSV vaccine

  2010cited by this paper
• Sipuleucel-T immunotherapy for castration-resistant prostate cancer.

  2010cited by this paper
• Strategies for Cancer Vaccine Development

  2010cited by this paper
• A decade of vaccines: Integrating immunology and vaccinology for rational vaccine design.

  2010cited by this paper
• Virus-host cell interactions in vaccine production cell lines infected with different human influenza A virus variants: a proteomic approach.

  2010cited by this paper
• Vaccines and the future of human immunology.

  2010cited by this paper
• Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap.

  2010cited by this paper
• Correlates of Protection Induced by Vaccination

  2010influential reference
• Immunology of vaccine adjuvants.

  2010cited by this paper
• Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

  2010cited by this paper
• Vaccine adjuvants: putting innate immunity to work.

  2010influential reference
• Systems vaccinology.

  2010cited by this paper
• Progress towards poliomyelitis eradication in Afghanistan and Pakistan, 2008.

  2009cited by this paper
• Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine.

  2009cited by this paper
• Vaccine development against Trypanosoma cruzi and Leishmania species in the post-genomic era.

  2009cited by this paper
• Impact of proteomics on anti-Mycobacterium tuberculosis (MTB) vaccine development.

  2009cited by this paper
• Dengue Virus Infection Induces Upregulation of GRP78, Which Acts To Chaperone Viral Antigen Production

  2009cited by this paper
• Proteomics by mass spectrometry: approaches, advances, and applications.

  2009influential reference
• Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics.

  2009cited by this paper
• Proteomic technology in the design of new effective antibacterial vaccines

  2009cited by this paper
• Labeling strategies in mass spectrometry-based protein quantitation.

  2009cited by this paper
• Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

  2009cited by this paper
• Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

  2009cited by this paper
• Development of a novel recombinant influenza vaccine in insect cells.

  2008cited by this paper

• Longitudinal proteomic and autoantibody signatures after mRNA vaccination in healthy individuals.

  2025cites this paper
• Cellular and Molecular Immunity to Influenza Viruses and Vaccines

  2024cites this paper
• A Standardized Protocol for Assuring the Validity of Proteomics Results from Liquid Chromatography–High-Resolution Mass Spectrometry

  2023cites this paper
• Proteomic analysis of canine vaccines.

  2023cites this paper
• Multi-epitope vaccine candidates based on mycobacterial membrane protein large (MmpL) proteins against Mycobacterium ulcerans

  2023cites this paper
• Multi-omics-based characterization of the influences of Mycobacterium tuberculosis virulence factors EsxB and PPE68 on host cells

  2023cites this paper
• An update on cerebral malaria for therapeutic intervention

  2022cites this paper
• Discovery of Schistosoma mekongi circulating proteins and antigens in infected mouse sera

  2022cites this paper
• Tuberculous Granuloma: Emerging Insights From Proteomics and Metabolomics

  2022cites this paper
• Nanoparticles of Chitosan/Poly(D,L-Lactide-Co-Glycolide) Enhanced the Immune Responses of Haemonchus contortus HCA59 Antigen in Model Mice

  2021cites this paper
• Predictive Markers of Immunogenicity and Efficacy for Human Vaccines

  2021cites this paper
• In vitro approaches for the evaluation of human vaccines

  2021cites this paper
• The Macrobrachium rosenbergii nodavirus: a detailed review of structure, infectivity, host immunity, diagnosis and prevention

  2021cites this paper
• In-silico identification of subunit vaccine candidates against lung cancer-associated oncogenic viruses

  2021cites this paper
• Mumps Outbreaks in Vaccinated Populations—Is It Time to Re-assess the Clinical Efficacy of Vaccines?

  2020cites this paper
• Contemporary vaccine approaches and role of next-generation vaccine adjuvants in managing viral diseases

  2020cites this paper
• The use of proteomics for the identification of promising vaccine and diagnostic biomarkers in Plasmodium falciparum

  2020cites this paper
• The combination of artificial intelligence and systems biology for intelligent vaccine design

  2020cites this paper
• Maternal Immunization: Nature Meets Nurture

  2020cites this paper
• Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine

  2020cites this paper
• OMIC Technologies and Vaccine Development: From the Identification of Vulnerable Individuals to the Formulation of Invulnerable Vaccines

  2019cites this paper
• Quantitative Mass Spectrometric Analysis of Autoantibodies as a Paradigm Shift in Autoimmune Serology

  2019cites this paper
• Proteomics as a tool for live attenuated influenza vaccine characterisation.

  2019cites this paper
• Mass Spectrometry Methods for Enhanced Characterization of Biological Systems

  2019cites this paper
• Profiling of local disease-sparing responses to bovine respiratory syncytial virus in intranasally vaccinated and challenged calves.

  2019cites this paper
• Development of a Chlamydia trachomatis vaccine for urogenital infections: novel tools and new strategies point to bright future prospects

  2018cites this paper
• Systems vaccinology and big data in the vaccine development chain

  2018cites this paper
• The role of proteomics in the age of immunotherapies

  2018cites this paper
• High‐sensitivity HLA class I peptidome analysis enables a precise definition of peptide motifs and the identification of peptides from cell lines and patients’ sera

  2016cites this paper